Effect of coffee and green tea consumption on the risk of liver cancer: Cohort analysis by hepatitis virus infection status

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 6, 2009, Pages 1746-1753

  Inoue, Manami ^a   Kurahashi, Norie ^a   Iwasaki, Motoki ^a   Shimazu, Taichi ^a   Tanaka, Yasuhito ^b   Mizokami, Masashi ^b   Tsugane, Shoichiro ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BEVERAGE; CANCER INCIDENCE; CANCER RISK; COFFEE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION; TEA;

ADULT; AGED; COFFEE; COHORT STUDIES; HEPATITIS B; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; INCIDENCE; JAPAN; LIVER NEOPLASMS; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; TEA;

EID: 67449100033     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0923     Document Type: Article

References (45)

1. IARC. IARC monographs on the evaluation of carcinogenic risks to humans, volume 51. Coffee, tea, mate, methylxanthines, and methylgloxyal. Lyon (France): IARC; 1991.
2. Tanaka T, Nishikawa A, Shima H, et al. Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. Basic Life Sci 1990;52:429-440
3. Jin X, Zheng RH, Li YM. Green tea consumption and liver disease: a systematic review. Liver Int 2008;28:990-996 (Pubitemid 352044448)
4. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: global perspective. Washington (DC): American Institute for Cancer Research; 2007.
5. Inoue M, Yoshimi I, Sobue T, Tsugane S. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005;97:293-300. (Pubitemid 40310277)
6. Kurozawa Y, Ogimoto I, Shibata A, et al. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 2005;93:607-610 (Pubitemid 43080007)
7. Shimazu T, Tsubono Y, Kuriyama S, et al. Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 2005;116:150-154 (Pubitemid 40827769)
8. Wakai K, Kurozawa Y, Shibata A, et al. Liver cancer risk, coffee, and hepatitis C virus infection: a nested case-control study in Japan. Br J Cancer 2007;97:426-428 (Pubitemid 47196758)
9. Ohishi W, Fujiwara S, Cologne JB, et al. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2008;17:846-854
10. Ohfuji S, Fukushima W, Tanaka T, et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: a case-control study. Hepatol Res 2006;36:201-208 (Pubitemid 44575932)
11. Tanaka K, Hara M, Sakamoto T, et al. Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan. Cancer Sci 2007;98:214-218 (Pubitemid 44941873)
12. Gallus S, Bertuzzi M, Tavani A, et al. Does coffee protect against hepatocellular carcinoma? Br J Cancer 2002;87:956-959
13. Gelatti U, Covolo L, Franceschini M, et al. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol 2005;42:528-534 (Pubitemid 40342932)
14. Montella M, Polesel J, La Vecchia C, et al. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer 2007;120:1555-1559 (Pubitemid 46355393)
15. Kuper H, Tzonou A, Kaklamani E, et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000;85:498-502. (Pubitemid 30075127)
16. Bravi F, Bosetti C, Tavani A, et al. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 2007;46:430-435 (Pubitemid 47344778)
17. Larsson SC, Wolk A. Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology 2007;132:1740-1745 (Pubitemid 46677953)
18. Nagano J, Kono S, Preston DL, Mabuchi K. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control 2001;12:501-508
19. Pisani P, Parkin DM, Munoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997;6:387-400.
20. The Editorial Board of the Cancer Statistics in Japan. Cancer statistics in Japan 2007. Tokyo: Foundation for Promotion of Cancer Research; 2007.
21. Tsugane S, Sobue T. Baseline survey of JPHC study-design and participation rate. Japan Public Health Center-Based Prospective Study on Cancer and Cardiovascular Diseases. J Epidemiol 2001;11:S24-9.
22. Abdel-Hamid M, El-Daly M, El-Kafrawy S, Mikhail N, Strickland GT, Fix AD. Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus. J Clin Microbiol 2002;40:1656-1659 (Pubitemid 34493135)
23. Committee for Evaluation of In vitro Diagnostic Devices, National Institute of Infectious Diseases. Re-evaluation of HBsAg detection kits approved for marketing in Japan. Jpn J Infect Dis 2001;54:201-207
24. WHO. International classification of diseases and health related problem, 10th revision. Geneva (Switzerland): WHO; 1990.
25. WHO. International classification of diseases for oncology. 3rd ed. Geneva (Switzerland): WHO; 2000.
26. Stata. Stata statistical software version 10. College Station (TX): Stata.
27. La Vecchia C. Coffee, liver enzymes, cirrhosis and liver cancer. J Hepatol 2005;42:444-446 (Pubitemid 40342918)
28. Tao KS, Wang W, Wang L, et al. The multifaceted mechanisms for coffee's anti-tumorigenic effect on liver. Med Hypotheses 2008;71:730-736
29. Urgert R, van der Weg G, Kosmeijer-Schuil TG, van de Bovenkamp P, Hovenier R, Katan MB. Levels of the cholesterol-evaluating diterpenes cafestol and kahweol in various coffee brews. J Agric Food Chem 1995;43:2167-2172
30. Tanaka K, Tokunaga S, Kono S, et al. Coffee consumption and decreased serum γ-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998;27:438-443 (Pubitemid 28336971)
31. Honjo S, Kono S, Coleman MP, et al. Coffee drinking and serum γ-glutamyltransferase: an extended study of Self-Defense Officials of Japan. Ann Epidemiol 1999;9:325-331 (Pubitemid 29289847)
32. Honjo S, Kono S, Coleman MP, et al. Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol 2001;54:823-829 (Pubitemid 32722187)
33. Poikolainen K, Vartiainen E. Determinants of γ-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee. Am J Epidemiol 1997;146:1019-1024 (Pubitemid 28030419)
34. Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005;128:24-32. (Pubitemid 40039955)
35. Corrao G, Zambon A, Bagnardi V, D'Amicis A, Klatsky A. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol 2001;11:458-465 (Pubitemid 32824109)
36. Gallus S, Tavani A, Negri E, La Vecchia C. Does coffee protect against liver cirrhosis? Ann Epidemiol 2002;12:202-205
37. Kim WR. Is coffee or tea good for your liver?. Nat Clin Pract Gastroenterol Hepatol 2006;3:482-483
38. Cadden IS, Partovi N, Yoshida EM. Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther 2007;26:1-8. (Pubitemid 46889833)
39. Nishikawa T, Nakajima T, Moriguchi M, et al. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. J Hepatol 2006;44:1074-1082
40. He P, Noda Y, Sugiyama K. Green tea suppresses lipopolysaccharide-induced liver injury in D-galactosamine-sensitized rats. J Nutr 2001;131:1560-1567 (Pubitemid 32422983)
41. Lynch SR. Interaction of iron with other nutrients. Nutr Rev 1997;55:102-110 (Pubitemid 27296372)
42. Fleming DJ, Jacques PF, Dallal GE, Tucker KL, Wilson PW, Wood RJ. Dietary determinants of iron stores in a free-living elderly population: the Framingham Heart Study. Am J Clin Nutr 1998;67:722-733 (Pubitemid 28153175)
43. Fleming DJ, Tucker KL, Jacques PF, Dallal GE, Wilson PW, Wood RJ. Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort. Am J Clin Nutr 2002;76:1375-1384 (Pubitemid 35416575)
44. Philippe MA, Ruddell RG, Ramm GA. Role of iron in hepatic fibrosis: one piece in the puzzle. World J Gastroenterol 2007;13:4746-4754 (Pubitemid 47455565)
45. Ministry of Health, Labour and Welfare, ed. The National Health and Nutrition Survey in Japan, 2005. Tokyo: Dai-ichi Shuppan; 2008.